Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Billie L, Durn"'
Autor:
Michael A. Tortorici, Theresa Yuraszeck, David Cornblath, Vera Bril, Hans‐Peter Hartung, Gen Sobue, Richard A. Lewis, Ingemar S. J. Merkies, John‐Philip Lawo, Michaela Praus, Billie L. Durn, Orell Mielke, Xuewen Ma, Petra Jauslin, Marc Pfister, Ivo N. vanSchaik, the PATH study group
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 8, Pp 839-850 (2021)
Abstract The two main objectives of this analysis were to (i) characterize the relationship between immunoglobulin (Ig) exposure and chronic inflammatory demyelinating polyneuropathy (CIDP) disease severity using data from 171 patients with CIDP who
Externí odkaz:
https://doaj.org/article/864b1de80a0d49abab9c2cf35b4c5ae2
Autor:
Hans-Peter Hartung, Vera Bril, Billie L. Durn, Monica Alcantara, John-Philip Lawo, Orell Mielke
Publikováno v:
Clinical Neurophysiology. 132:2184-2190
Objective To assess axonal function prior to subcutaneous immunoglobulin (SCIG) therapy or placebo in relation to relapse in chronic inflammatory demyelinating polyneuropathy (CIDP) to determine whether axonal damage can predict therapy response. Met
Autor:
Theresa Yuraszeck, Michael A. Tortorici, Billie L. Durn, Hans-Peter Hartung, Orell Mielke, Vera Bril, Ivo N. van Schaik, David R. Cornblath, Marc Pfister, Gen Sobue, Ingemar S. J. Merkies, Xuewen Ma, Michaela Praus, John-Philip Lawo, Richard A. Lewis, Petra M. Jauslin
Publikováno v:
CPT: Pharmacometrics and Systems Pharmacology, 10(8), 839-850. Wiley
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 8, Pp 839-850 (2021)
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 8, Pp 839-850 (2021)
The two main objectives of this analysis were to (i) characterize the relationship between immunoglobulin (Ig) exposure and chronic inflammatory demyelinating polyneuropathy (CIDP) disease severity using data from 171 patients with CIDP who received
Autor:
Orell Mielke, H.-P. Hartung, Billie L. Durn, R. Mallick, Vera Bril, Richard A. Lewis, I. N. van Schaik, John-Philip Lawo, I. S. J. Merkies, David R. Cornblath, Gen Sobue
Publikováno v:
European Journal of Neurology, 27(1), 196-203. Wiley
Background and purpose Chronic inflammatory demyelinating polyneuropathy (CIDP) causes weakness which adversely impacts function and quality of life (QOL). CIDP often requires long-term management with intravenous or subcutaneous immunoglobulin. The
Autor:
Martin Stangel, K. George, Inna Rubanovits, A. Kutschenko, Michael Schroeter, Juliane Klehmet, Tsugio Akutsu, Robert D. Henderson, S. Mumfrey, Takuya Ohkubo, Helmar C. Lehmann, Mari Auranen, Paul Bassett, Giuseppe Lauria, A. Di Muzio, Kenichi Kaida, David Yarnitsky, S. Larue, R. Gold, Fabian Klostermann, Karissa L. Gable, Ivo N. van Schaik, Gens Sobue, A Schenone, U. Sorro, Jeffrey A. Allen, S. Attarian, A. Algom, U. Chyrchel-Paszkiewicz, J. Haas, Jens Ejbye Schmidt, I. N. van Schaik, Jasper M. Morrow, Ingemar S. J. Merkies, R. Carne, C. Marquez Infante, Michael P. Lunn, Khema Sharma, E. Chi Ho Lai, Billie L. Durn, Satoshi Kuwabara, D. Kramer, David Gosal, P. MacDonald, Janneke G. J. Hoeijmakers, Giovanni Antonini, Senda Ajroud-Driss, S. Muley, Takanori Yokota, Tim Hagenacker, Eroboghene E. Ubogu, M. Kawai, Maria Salvado, Jean Pouget, Mika Saarela, John T. Kissel, Alexander Shtilbans, K. Kanai, B. Murinson, Olaf Hoffmann, Claudia Sommer, Sandro Sorbi, P. Berlit, Norman Latov, Nora A. Visser, C. G. Faber, A. Wielanek, J. Demeestere, Ericka Simpson, Ginna Gonzalez, Konrad Rejdak, C. Casanovas Pons, Alessandro Testori, Orell Mielke, T. Kalous, Alexa Cleasby, Vera Bril, J. Sussova, D. Mueller, Katrin Gross-Paju, Dale J. Lange, Nicolette C. Notermans, Florian Then Bergh, R. Talab, Kazumasa Yokoyama, M. Zibetti, C. Trebst, Marina Grandis, Miriam Freimer, E. Delmon, David R. Cornblath, Masahiro Mori, H. Onoue, Richard J. Barohn, D. Liebetanz, M. Chatzopoulos, J. Oechtering, F. Ciccocioppo, T. Rao, P. Van Damme, A. Sabet, Takashi Kanda, J. Zschuentzsch, Hans-Peter Hartung, S. Benitez, D. Aufauvre, M. Bednar, M. Tomiyama, G. Le Masson, C. D'Amour, Richard A. Lewis, Anne D. Sperfeld, I. Melamed, Lisa D. Hobson-Webb, Stefan Blum, Dario Cocito, K. Nishiyama, Daniele Cazzato, F. Bethke, Toomas Toomsoo, Said R. Beydoun, Leslie Roberts, David Walk, Josep Gamez, Masahiro Iijima, A. Jaspert-Grehl, Israel V. Drory, P. Kunc, John-Philip Lawo, C. Goerlitz, H. Johl, R. Yoon, Daniela M. Menichella, T. Lavin, Stefania Morino, K. Ohyama, Masayuki Baba, M. Antonia, Shafeeq Ladha, Claude Desnuelle, Pierre Clavelou, Andreas Meisel, Martin Vališ, Filip Eftimov, P. Baum, Sabrina Matà, Russell L. Chin, Mazen M. Dimachkie
Publikováno v:
Journal of the peripheral nervous system, 25(3), 230-237. Wiley-Blackwell
Journal of the Peripheral Nervous System
Journal of the Peripheral Nervous System
The Polyneuropathy And Treatment with Hizentra (PATH) study required subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) to show dependency on immunoglobulin G (IgG) and then be restabilized on IgG before being randomized to placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43063fcd25f2793a6b2337f883a18156
https://pure.amc.nl/en/publications/placebo-effect-in-chronic-inflammatory-demyelinating-polyneuropathy-the-path-study-and-a-systematic-review(82ad0dca-304a-4f5e-9f95-296f8e71a555).html
https://pure.amc.nl/en/publications/placebo-effect-in-chronic-inflammatory-demyelinating-polyneuropathy-the-path-study-and-a-systematic-review(82ad0dca-304a-4f5e-9f95-296f8e71a555).html
Autor:
Billie L. Durn, Orell Mielke, I.S.J. Merkies, H.-P. Hartung, David R. Cornblath, Vera Bril, J.P. Lawo, Gen Sobue, Richard A. Lewis, N. van Geloven, I. N. van Schaik, M. M. Dimachkie
Publikováno v:
Muscle & Nerve. 56:S1-S16
Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) often require long-term intravenous immunoglobulin (IVIG) maintenance therapy. Subcutaneous immunoglobulin (SCIG) offers an alternative administration option with anticipated impr
Autor:
Alphonse Hubsch, Abdulgabar Salama, Stefano Fontana, Orell Mielke, Vesselina Goranova-Marinova, Sandra Wymann, Billie L. Durn, Martin O. Spycher, John P. Lawo, Amgad Shebl
Publikováno v:
Transfusion. 57:2629-2638
BACKGROUND Patients treated with intravenous immunoglobulins (IVIG) rarely experience symptomatic hemolysis. Although anti-A and anti-B isoagglutinins from the product are involved in most cases, the actual mechanisms triggering hemolysis are unclear
Autor:
Ingemar S. J. Merkies, Vera Bril, Gen Sobue, John-Philip Lawo, Richard A. Lewis, David R. Cornblath, Xuewen Ma, Billie L. Durn, Michael A. Tortoricci, Theresa Yuraszeck, Ivo N. van Schaik, Orell Mielke, Hans-Peter Hartung
Publikováno v:
Clinical Neurophysiology. 131:e9-e10
Autor:
Nan Geloven van, Hans-Peter Hartung, Orell Mielke, Amgad Shebl, Ingemar S. J. Merkies, John-Philip Lawo, Ivo N. van Schaik, Gen Sobue, Vera Bril, Billie L. Durn, David R. Cornblath, Richard A. Lewis
Publikováno v:
Clinical Neurophysiology. 131:e7-e8
Autor:
Orell Mielke, Ivo N. van Schaik, Theresa Yuraszeck, John-Philip Lawo, Billie L. Durn, Hans-Peter Hartung, Vera Bril, Richard A. Lewis, Gen Sobue, Michael A. Tortoricci, Xuewen Ma, Ingemar S. J. Merkies, David R. Cornblath
Publikováno v:
Clinical Neurophysiology. 131:e8-e9